HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

Science
Chiara BoniniClaudio Bordignon

Abstract

In allogeneic bone marrow transplantation (allo-BMT), donor lymphocytes play a central therapeutic role in both graft-versus-leukemia (GvL) and immune reconstitution. However, their use is limited by the risk of severe graft-versus-host disease (GvHD). Eight patients who relapsed or developed Epstein-Barr virus-induced lymphoma after T cell-depleted BMT were then treated with donor lymphocytes transduced with the herpes simplex virus thymidine kinase (HSV-TK) suicide gene. The transduced lymphocytes survived for up to 12 months, resulting in antitumor activity in five patients. Three patients developed GvHD, which could be effectively controlled by ganciclovir-induced elimination of the transduced cells. These data show that genetic manipulation of donor lymphocytes may increase the efficacy and safety of allo-BMT and expand its application to a larger number of patients.

References

Jan 1, 1991·Human Gene Therapy·K W CulverR M Blaese
Jun 16, 1989·Science·T Friedmann
Feb 1, 1986·Annals of Internal Medicine·E D ThomasK Doney
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·Y C ChengS P Grill
Oct 1, 1994·Current Opinion in Immunology·H WaldmannG Hale
Jan 13, 1994·The New England Journal of Medicine·D L PorterJ H Antin

❮ Previous
Next ❯

Citations

Dec 14, 1999·Journal of Clinical Apheresis·H E HeslopC M Rooney
Feb 24, 2001·The Journal of Gene Medicine·M GladowW Uckert
Jul 5, 2001·Hematological Oncology·B J HennessyM N Potter
Jun 10, 1998·Springer Seminars in Immunopathology·F Candotti, R M Blaese
Sep 2, 1998·Immunologic Research·C M Seroogy, C G Fathman
Dec 5, 2002·International Journal of Hematology·Fabio Ciceri, Claudio Bordignon
Nov 15, 2002·International Journal of Hematology·Stanley R RiddellE H Warren
Apr 8, 2010·Archivum Immunologiae Et Therapiae Experimentalis·David Marc Davies, John Maher
Aug 10, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Marek Jakóbisiak, Jakub Gołab
Aug 23, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Vania KenanovaAnna M Wu
Jan 19, 2005·Cancer Immunology, Immunotherapy : CII·Ida Aagård HedforsJan E Brinchmann
Jul 27, 2005·Cancer Immunology, Immunotherapy : CII·Ulrich T HackerSusan B S King
Feb 4, 2009·Cancer Immunology, Immunotherapy : CII·Wolfgang Uckert, Ton N M Schumacher
Oct 23, 2009·Cancer Immunology, Immunotherapy : CII·Rosaely Casalegno-GarduñoMichael Schmitt
Feb 25, 2009·Clinical and Experimental Medicine·Michela Cesco-GaspereHans J Stauss
Dec 12, 2012·Current Allergy and Asthma Reports·Sivasubramanian Baskar, Natarajan Muthusamy
Aug 12, 2006·Current Oncology Reports·Esperanza B Papadopoulos, Ann A Jakubowski
Mar 13, 2012·International Journal of Hematology·Sepideh KhaleghiPhilippe Pognonec
Jan 22, 2004·Archives of Medical Research·Juan A BuerenJosé C Segovia
Jan 29, 2000·Journal of Immunological Methods·W A MarascoA Winkler
Mar 15, 2001·Antiviral Research·P Wutzler, R Thust
Jan 19, 2000·Immunology Today·S LalP G Schlegel
Mar 12, 2003·Trends in Biotechnology·Kenneth Lundstrom
Sep 16, 1999·Journal of Biotechnology·K A BerlynR W Malone
May 17, 2003·European Journal of Medicinal Chemistry·Loredana SpadolaLeonardo Scapozza
Jul 5, 2003·Experimental Hematology·Imad A Tabbara, Richard M Ingram
Oct 11, 2003·Experimental Hematology·Richard K BurtCharles Link
Mar 3, 2001·Current Opinion in Immunology·C YeeP D Greenberg
Nov 22, 1997·Current Opinion in Immunology·C YeeP D Greenberg
Oct 6, 1999·Current Opinion in Immunology·W J Murphy, B R Blazar
Oct 18, 2000·Transfusion Science·M Schleuning
Apr 20, 2001·Critical Reviews in Oncology/hematology·N BasaraA A Fauser
Apr 25, 2003·Critical Reviews in Oncology/hematology·Shimon SlavinReuven Or

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.